Lataa...
Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children
Piperacillin-tazobactam (TZP) is frequently used to treat severe hospital-acquired infections in children. We performed a single-center, pharmacokinetic (PK) trial of TZP in children ranging in age from 2 months to 6 years from various clinical subpopulations. Children who were on TZP per the standa...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811421/ https://ncbi.nlm.nih.gov/pubmed/31427292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01260-19 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|